Suppression of choroidal neovascularization by intramuscular polymer-based gene delivery of vasostatin

Experimental Eye Research

Volumn 81, Issue 6, 2005, Pages 673-679

  Sheu, Shwu Jiuan ^a,b   Chou, Li Chen ^a   Bee, Youn Shen ^a   Chen, Jane Fane ^a   Lin, Hsiu Chen ^a   Lin, Pey Ru ^a   Lam, Hsing Chun ^a   Tai, Ming Hong ^a,c  

^a KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

Author keywords

Choroidal neovascularization; Gene delivery; Polymer; Vasostatin

Indexed keywords

ANGIOGENESIS INHIBITOR; FLUORESCEIN; POVIDONE; UNCLASSIFIED DRUG; VASOSTATIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARGON LASER; ARTICLE; CELL PROLIFERATION; CELL STRAIN 3T3; CELL VIABILITY; CONTROLLED STUDY; COW; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG RELEASE; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL MODEL; EXPRESSION VECTOR; FEMALE; FLUORESCENCE ANGIOGRAPHY; GENE CONSTRUCT; GENE TARGETING; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; LASER COAGULATION; MAMMAL; MOUSE; MUSCLE CELL; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NONVIRAL GENE THERAPY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS REGULATION; RAT; SUBRETINAL NEOVASCULARIZATION; WESTERN BLOTTING;

ANGIOGENESIS INHIBITORS; ANIMALS; CALRETICULIN; CHOROIDAL NEOVASCULARIZATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEASIBILITY STUDIES; GENE EXPRESSION; GENE THERAPY; GENETIC VECTORS; INJECTIONS, INTRAMUSCULAR; LIGHT COAGULATION; PEPTIDE FRAGMENTS; RATS; RATS, INBRED BN; TRANSFECTION;

EID: 29044449005     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2005.04.005     Document Type: Article

References (18)

1. A. Auricchio, K.C. Behling, A.M. Maguire, E.M. O'Connor, J. Bennett, J.M. Wilson, and M.J. Tolentino Inhibition of retinal neovascularization by intraocular viral-mediated delivery of anti-angiogenic agents Mol. Ther. 6 2002 490 494
2. J. Bennett Immune response following intraocular delivery of recombinant viral vectors Gene. Ther. 10 2003 977 982
3. P. Blezinger, J. Wang, M. Gondo, A. Quezada, D. Mehrens, M. French, A. Singhal, S. Sullivan, A. Rolland, R. Ralston, and W. Min Systemic inhibition of tumour growth and tumour metastases by intramuscular administration of the endostatin gene [In Process Citation] Nat. Biotechnol. 17 1999 343 348
4. P.A. Campochiaro Retinal and choroidal neovascularization J. Cell. Physiol. 184 2000 301 310
5. D.W. Dawson, O.V. Volpert, P. Gillis, S.E. Crawford, H. Xu, W. Benedict, and N.P. Bouck Pigment epithelium-derived factor: A potent inhibitor of angiogenesis Science 285 1999 245 248
6. M.A. Konerding Ocular angiogenesis: Translating preclinical indications to successful clinical development Expert Opin. Ther. Targets 8 2004 255 258
7. C.C. Lai, W.C. Wu, S.L. Chen, X. Xiao, T.C. Tsai, S.J. Huan, T.L. Chen, R.J. Tsai, and Y.P. Tsao Suppression of choroidal neovascularization by adeno-associated virus vector expressing angiostatin Invest. Ophthalmol. Vis. Sci. 42 2001 2401 2407
8. R.J. Mumper, J.G. Duguid, K. Anwer, M.K. Barron, H. Nitta, and A.P. Rolland Polyvinyl derivatives as novel interactive polymers for controlled gene delivery to muscle Pharm. Res. 13 1996 701 709
9. R.J. Mumper, J. Wang, S.L. Klakamp, H. Nitta, K. Anwer, F. Tagliaferri, and A.P. Rolland Protective interactive noncondensing (PINC) polymers for enhanced plasmid distribution and expression in rat skeletal muscle J. Control. Release 52 1998 191 203
10. M.S. O'Reilly, L. Holmgren, Y. Shing, C. Chen, R.A. Rosenthal, M. Moses, W.S. Lane, Y. Cao, E.H. Sage, and J. Folkman Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma Cell 79 1994 315 328
11. M.S. O'Reilly, T. Boehm, Y. Shing, N. Fukai, G. Vasios, W.S. Lane, E. Flynn, J.R. Birkhead, B.R. Olsen, and J. Folkman Endostatin: an endogenous inhibitor of angiogenesis and tumour growth Cell 88 1997 277 285
12. S.E. Pike, L. Yao, K.D. Jones, B. Cherney, E. Appella, K. Sakaguchi, H. Nakhasi, J. Teruya-Feldstein, P. Wirth, G. Gupta, and G. Tosato Vasostatin, a calreticulin fragment, inhibits angiogenesis and suppresses tumour growth J. Exp. Med. 188 1998 2349 2356
13. S.E. Pike, L. Yao, J. Setsuda, K.D. Jones, B. Cherney, E. Appella, K. Sakaguchi, H. Nakhasi, C.D. Atreya, and J. Teruya-Feldstein Calreticulin and calreticulin fragments are endothelial cell inhibitors that suppress tumour growth Blood 94 1999 2461 2468
14. S.J. Reich, and J. Bennett Gene therapy for ocular neovascularization: a cure in sight Curr. Opin. Genet. Dev. 13 2003 317 322
15. P.-C. Wu, L.-C. Yang, H.-K. Kuo, C.-C. Huang, C.-L. Tsai, P.-R. Lin, P.-C. Wu, S.-J. Shin, and M.-H. Tai Inhibition of corneal angiogenesis by local application of vasostatin Mol. Vis. 11 2005 28 35
16. F. Xiao, Y. Wei, L. Yang, X. Zhao, L. Tian, Z. Ding, S. Yuan, Y. Lou, F. Liu, and Y. Wen A gene therapy for cancer based on the angiogenesis inhibitor, vasostatin Gene. Ther. 9 2002 1207 1213
17. L. Yao, S.E. Pike, J. Setsuda, J. Parekh, G. Gupta, M. Raffeld, E.S. Jaffe, and G. Tosato Effective targeting of tumour vasculature by the angiogenesis inhibitors vasostatin and interleukin-12 Blood 96 2000 1900 1905
18. D. Zacks, E. Ezra, Y. Terada, N. Michaud, E. Connolly, E.S. Gragoudas, and J.W. Miller Vereporfin photodynamic therapy in the rat model of choroidal neovascularization: angiographic and histological characterization Invest. Ophthalmol. Vis. Sci. 43 2002 2384 2391